Oura shelves a $2.2B IPO that would have added $6.2M to its cash

Oura postponed its initial public offering indefinitely on September 29, citing “uncertainty in the IPO market,” as TechCrunch reported. The coverage led on the deal size, up to $2.2 billion. Oura’s own prospectus shows the offering would have added about $6.2 million to the company’s cash.

The reason sits in the share split, and it was public eight days before the postponement. The amended registration statement filed on September 21 put 50,000,000 shares on offer, of which Oura was selling 13,500,000 and existing stockholders were selling 36,500,000. “We will not receive any of the proceeds from the sale of the shares being sold by the selling stockholders,” the filing says. So roughly three quarters of the headline number was never Oura’s money.

The company’s own slice came to about $532.6 million in net proceeds at the $42.00 midpoint of the range. The filing then commits approximately $526.4 million of that to tax withholding on a settlement of employee restricted stock units, at an assumed withholding rate of 47.7%. Everything left over was going to general corporate purposes, so the discretionary portion was small.

You can read the result off the balance sheet, because the prospectus prints both columns. Cash and cash equivalents stood at $371.8 million as of June 30, 2026, and the pro forma as adjusted column shows $377.9 million. That’s a $6.2 million difference, and it’s the clearest measure of what the offering was actually for.

Item	Figure in the September 21 filing
Shares offered	50,000,000
Sold by Oura	13,500,000
Sold by existing stockholders	36,500,000
Price range	$40.00 to $44.00
Net proceeds to Oura at $42.00	$532.6 million
Committed to employee share taxes	$526.4 million
Cash at June 30, 2026	$371.8 million
Cash, pro forma as adjusted	$377.9 million

The share count the coverage got wrong

TechCrunch reported that Oura had filed to offer 55 million shares. The prospectus cover says 50,000,000, and the only other block is an option on up to 7,500,000 additional shares that the underwriters could buy from the selling stockholders, not from Oura. CNBC’s 50 million matches the filing.

The deal size itself was reported two ways, and both are defensible. TechCrunch used $2.2 billion, which is 50,000,000 shares at the top of the range. Semafor said $2 billion, which is the same share count at the bottom. The midpoint works out at $2.1 billion.

We aim to deliver an extraordinary IPO for our employees and investors and we have the luxury of choosing our moment. In the meantime, we will execute against the opportunities ahead.

Tom Hale, CEO of Oura, via CNBC

Semafor reported that indications the shares would price at the low end of the range delayed the plans, according to a person familiar with the matter. It also noted the Nasdaq is hitting record highs, which makes “uncertainty” an odd word for the moment. Samuel Kerr, global head of equity capital markets at Mergermarket, told CNBC that rising sovereign debt yields are spooking investors and pushing some to ask for far wider discounts.

What the filing says about growth, and what it doesn’t

Both outlets reported that Oura expects revenue to grow 90% year over year in fiscal 2026, which ends on September 30. The filing’s own forward-looking statement is narrower than that. It says Oura expects to end fiscal 2026 with approximately 5.7 million Paid Members, representing 96% year-over-year growth. That’s the only quantified forecast in the document, because the prospectus carries no revenue projection anywhere.

Still, the reported numbers are strong, and that’s part of why the postponement reads oddly. Revenue reached $1,214.5 million in the nine months to June 30, 2026, up 74% on the same period a year earlier, after fiscal 2025 revenue of $907.9 million. Membership gross margins ran at 89% over those nine months. The Oura Ring 5, launched in May and 40% smaller than its predecessor, is what the company credits for the recent momentum.

One detail no write-up in our source set mentioned: the filing named two cornerstone investors. Eli Lilly and Company indicated an interest in buying up to $100.0 million of stock, and funds affiliated with Dragoneer Investment Group indicated up to $300.0 million. The filing stresses those indications aren’t binding commitments, so neither firm was obliged to buy anything.

Forerunner Ventures shows that structure most plainly. Entities affiliated with the firm held 28,679,908 shares, or 9.3%, and the selling stockholder table shows all of them on offer, leaving Forerunner at zero. That pattern of early backers taking the liquidity is the part a round or listing announcement usually leaves out.

What’s worth watching is the paperwork rather than the statement. EDGAR shows no request to withdraw the registration as of October 1, which is the step Holtec Nuclear took earlier in September. Oura’s registration statement is therefore still on file, which means the next concrete signal is an amended filing rather than a press statement. If a new range comes back lower, it joins the growing list of valuations that reset on the way to a deal.